Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review
CONCLUSION: TTSs are primarily effective for delivering small molecules. The use of absorption enhancers and irritation mitigators can be necessary to enhance the performance. The development of these technologies is essential for the convenience of patients and caregivers.PMID:37990896 | DOI:10.2174/0118715273275957231102044934
Source: CNS and Neurological Disorders Drug Targets - Category: Drugs & Pharmacology Authors: Let ícia Basso Silvia Cristina Fagundes Tatiana Staudt Karini da Rosa Elizane Langaro Hamid Omidian Charise Dallazem Bertol Source Type: research
More News: Alzheimer's | Brain | Donepezil | Drugs & Pharmacology | Namenda | Neurology | Physiology | Skin | Study